Hester Biosciences

Hester Biosciences EBIT

The EBIT of Hester Biosciences (HESTERBIO.NS) as of Nov 21, 2026 is 677.77 M INR. In the previous year, EBIT was 455.05 M INR — a change of 48.94% (higher).

EBIT

677.77 MINR

YoY

48.94%

Last updated:

In 2026, Hester Biosciences's EBIT was 677.77 M INR, a 48.94% increase from the 455.05 M INR EBIT recorded in the previous year.

The Hester Biosciences EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2019
625.78 M INR
Jan 1, 2020
468.59 M INR
Jan 1, 2021
567.84 M INR
Jan 1, 2022
1.25 B INR
Jan 1, 2023
310.27 M INR
Jan 1, 2024
364.77 M INR
Jan 1, 2025
455.05 M INR
Jan 1, 2026
677.77 M INR
The Hester Biosciences EBIT history
YEAREBITYoY
677.77 MINR+48.94%
455.05 MINR+24.75%
364.77 MINR+17.57%
310.27 MINR-75.23%
1.25 BINR+120.56%
567.84 MINR+21.18%
468.59 MINR-25.12%
625.78 MINR+58.15%
395.70 MINR+28.53%
307.85 MINR+26.53%
243.31 MINR+43.26%
169.84 MINR+27.25%
133.47 MINR-7.35%
144.07 MINR-2.16%
147.25 MINR+7.39%
137.11 MINR+14.62%
119.62 MINR+8.36%
110.40 MINR-18.61%
135.64 MINR+55.38%
87.30 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hester Biosciences Revenue

Hester Biosciences Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
1.78 B INR
625.78 M INR
415.67 M INR
Jan 1, 2020
1.83 B INR
468.59 M INR
291.71 M INR
Jan 1, 2021
2.14 B INR
567.84 M INR
344.30 M INR
Jan 1, 2022
2.35 B INR
1.25 B INR
393.20 M INR
Jan 1, 2023
2.66 B INR
310.27 M INR
266.27 M INR
Jan 1, 2024
3.05 B INR
364.77 M INR
188.89 M INR
Jan 1, 2025
3.11 B INR
455.05 M INR
274.88 M INR
Jan 1, 2026
3.33 B INR
677.77 M INR
556.39 M INR

Hester Biosciences Margins

Hester Biosciences stock margins

The Hester Biosciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Hester Biosciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Hester Biosciences.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
70.56 %
35.14 %
23.34 %
Jan 1, 2020
73.70 %
25.57 %
15.92 %
Jan 1, 2021
73.69 %
26.49 %
16.06 %
Jan 1, 2022
70.70 %
53.29 %
16.73 %
Jan 1, 2023
70.88 %
11.66 %
10.01 %
Jan 1, 2024
31.94 %
11.98 %
6.20 %
Jan 1, 2025
67.01 %
14.63 %
8.84 %
Jan 1, 2026
50.84 %
20.38 %
16.73 %

Hester Biosciences Stock analysis

What does Hester Biosciences do? Hester Biosciences Ltd. generates revenue through its four operational segments: Poultry Healthcare, Animal Healthcare, Petcare, and Others. The company sells poultry vaccines such as Gumboro I, Inactivated ND IB, and Live H120, alongside animal health products including Goat Pox Vaccine and PPR Vaccine - Nigerian 75/1. Petcare offerings like Cefshot Tazo Injection and Hestacef CV target veterinary clinics and pet owners. The firm serves agricultural businesses, veterinary practitioners, and pet care providers across India, with its products distributed through trade channels and direct sales to livestock farmers and clinics. Animal Healthcare segment focuses on livestock protection with vaccines for goats and cattle, while Poultry Healthcare provides specialized immunizations for commercial poultry farms. Diagnostic laboratory services complement the product portfolio, supporting livestock health management. The company's product range caters to both large-scale farming operations and smaller veterinary practices, ensuring consistent demand across its target markets. Revenue streams are derived from direct sales to farmers and veterinary clinics, as well as trade distribution networks. The firm's portfolio includes thermostable vaccines for poultry, such as Thermostable ND, which appeals to commercial poultry producers seeking reliable disease prevention solutions. Petcare products like Hestaflam Tablet are marketed to pet owners and veterinary hospitals, expanding the company's reach beyond traditional agricultural sectors. Hester Biosciences is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Hester Biosciences's EBIT

Hester Biosciences's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Hester Biosciences's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Hester Biosciences's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Hester Biosciences’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Hester Biosciences stock

EBIT of Hester Biosciences is 677.77 M INR in 2026.

EBIT of Hester Biosciences changed from 455.05 M INR to 677.77 M INR, representing a 48.94% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Hester Biosciences since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Hester Biosciences historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Hester Biosciences

All Key Metrics — Hester Biosciences